A Clinical Research on SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration
Latest Information Update: 06 Jan 2026
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary)
- Indications Intervertebral disc degeneration
- Focus Therapeutic Use
- Sponsors Sclnow Biotechnology
Most Recent Events
- 04 Dec 2025 Planned End Date changed from 30 Jun 2026 to 31 Dec 2026.
- 04 Dec 2025 Planned primary completion date changed from 31 Dec 2025 to 30 Jun 2026.
- 04 Dec 2025 Planned initiation date changed from 30 Jun 2025 to 31 Dec 2025.